Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 May:187:114387.
doi: 10.1016/j.bcp.2020.114387. Epub 2021 Jan 5.

Purinergic receptors in airway hydration

Affiliations
Review

Purinergic receptors in airway hydration

Eduardo R Lazarowski et al. Biochem Pharmacol. 2021 May.

Abstract

Airway epithelial purinergic receptors control key components of the mucociliary clearance (MCC), the dominant component of pulmonary host defense. In healthy airways, the periciliary liquid (PCL) is optimally hydrated, thus acting as an efficient lubricant layer over which the mucus layer moves by ciliary force. When the hydration of the airway surface decreases, the mucus becomes hyperconcentrated, the PCL collapses, and the "thickened" mucus layer adheres to cell surfaces, causing plaque/plug formation. Mucus accumulation is a major contributing factor to the progression of chronic obstructive lung diseases such as cystic fibrosis (CF) and chronic bronchitis (CB). Mucus hydration is regulated by finely tuned mechanisms of luminal Cl- secretion and Na+ absorption with concomitant osmotically driven water flow. These activities are regulated by airway surface liquid (ASL) concentrations of adenosine and ATP, acting on airway epithelial A2B and P2Y2 receptors, respectively. The goal of this article is to provide an overview of our understanding of the role of purinergic receptors in the regulation of airway epithelial ion/fluid transport and the mechanisms of nucleotide release and metabolic activities that contribute to airway surface hydration in healthy and chronically obstructed airways.

Keywords: ATP hydrolysis; Airway epithelia; Airway hydration; Nucleotide release; Purinergic receptors.

PubMed Disclaimer

Conflict of interest statement

No conflicts of interest, financial or otherwise, are declared by the authors.

Figures

Figure 1.
Figure 1.. Regulation of mucus hydration in airway epithelia.
A, airway surface hydration is maintained by water fluxes mainly driven by active Cl and Na+ transport. When the hydration of the airway surface decreases, e.g., secondary to CFTR dysfunction, Na+ absorption increases, the mucus becomes hyperconcentrated, the PCL collapses, and the “thickened” mucus layer adheres to the cell surface, causing plaque/plug formation, as seen in CF and CB. B, ATP and adenosine (Ado) acting on airway epithelial P2Y2R and A2BR, respectively, promote Cl secretion and inhibition of Na+ absorption.
Figure 2.
Figure 2.. Purinergic regulation of mucus hydration and clearance.
ATP is released from non-mucous cells via the plasma membrane channel pannexin 1 (PANX1). Goblet cell mucin granules release ATP and, to a greater extent, ADP and AMP. A subset of ecto-enzymes (not shown for clarity) convert released ATP to ADP, AMP, and adenosine (Ado). The A2BR and the P2Y2R on non-mucous cells are major regulators of ASL volume production, via activation of the CFTR and CACC, and promote inhibition of Na+ absorption. P2Y2RS expressed on goblet cells promote mucin secretion.
Figure 3.
Figure 3.. Inhibition of ATP hydrolysis improves ASL volume regulation in CF HBE cells.
CF HBE cells were maintained at an air-liquid interface overnight under phasic motion (0.5 dynes/cm2, 14 cycles/min) [62]. Afterwards, PBS or PBS containing 1 mM POM-5 were applied via an Aeroneb Lab Nebulizer (final [POM-5] = 100 μM; volume applied =100 nl) and ASL height was measured by confocal microscopy, as in [62]. A, representative confocal microscopy image taken at 60 min in the absence (PBS) or presence of 100 μM POM-5; bar =10 μm. B, quantification of ASL height in CF HBE cells. The data represent the mean ± SD (4 cultures / condition; *, p < 0.05) and are representative of two independent experiments. Reproduced from van Heusden et al. 2020. Am J Physiol Lung Cell Mol Physiol 318, L356-L365A [23].

References

    1. Burnstock G, Campbell G, Satchell D, Smythe A, Evidence that adenosine triphosphate or a related nucleotide is the transmitter substance released by non-adrenergic inhibitory nerves in the gut, Br. J. Pharmacol 120(4 Suppl) (1970) 337–357. - PMC - PubMed
    1. Burnstock G, Purinergic nerves, Pharmacol. Rev 24(3) (1972) 509–581. - PubMed
    1. Burnstock G, A basis for distinguishing two types of purinergic receptor, in: Straub LB (Ed.), Cell Membrane Receptors for Drugs and Hormones: A Multidisciplinary Approach, Raven Press, New York, 1978, pp. 107–118.
    1. Burnstock G, Kennedy C, Is there a basis for distinguishing two types of P2-purinoceptor?, Gen. Pharmacol 16 (1985) 433–440. - PubMed
    1. Ralevic V, Burnstock G, Receptors for purines and pyrimidines, Pharmacol. Rev 50(3) (1998) 413–492. - PubMed

Publication types

MeSH terms